Antagonism of EG-VEGF receptors is a novel targeted therapy for choriocarcinoma progression: in vitro, in vivo and in clinical studies
BALBONI, GIANFRANCO;
2017-01-01
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.